Detalhe da pesquisa
1.
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors.
World J Urol
; 41(11): 2967-2974, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37787941
2.
Nationwide analysis of survival after radical cystectomy for bladder cancer in Finland.
Acta Oncol
; 62(8): 829-835, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37377029
3.
Qualitative and Quantitative Reporting of a Unique Biparametric MRI: Towards Biparametric MRI-Based Nomograms for Prediction of Prostate Biopsy Outcome in Men With a Clinical Suspicion of Prostate Cancer (IMPROD and MULTI-IMPROD Trials).
J Magn Reson Imaging
; 51(5): 1556-1567, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31750988
4.
Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score.
J Magn Reson Imaging
; 51(4): 1075-1085, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31566845
5.
Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial.
PLoS Med
; 16(6): e1002813, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31158230
6.
Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial).
Eur J Nucl Med Mol Imaging
; 45(3): 355-364, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29147764
7.
Novel biparametric MRI and targeted biopsy improves risk stratification in men with a clinical suspicion of prostate cancer (IMPROD Trial).
J Magn Reson Imaging
; 46(4): 1089-1095, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28165653
8.
Awareness of Smoking as a Risk Factor in Bladder Cancer: Results from the Prospective FinnBladder 9 Trial.
Eur Urol Focus
; 8(5): 1246-1252, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35094962
9.
The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk Calculator.
Eur Urol Open Sci
; 41: 45-54, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35813258
10.
Negative Predictive Value of Biparametric Prostate Magnetic Resonance Imaging in Excluding Significant Prostate Cancer: A Pooled Data Analysis Based on Clinical Data from Four Prospective, Registered Studies.
Eur Urol Focus
; 7(3): 522-531, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32418878
11.
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD).
Eur Urol Oncol
; 4(6): 971-979, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32972896
12.
Impact of biparametric prebiopsy prostate magnetic resonance imaging on the diagnostics of clinically significant prostate cancer in biopsy naïve men.
Scand J Urol
; 54(1): 7-13, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31914846
13.
Prebiopsy IMPROD Biparametric Magnetic Resonance Imaging Combined with Prostate-Specific Antigen Density in the Diagnosis of Prostate Cancer: An External Validation Study.
Eur Urol Oncol
; 3(5): 648-656, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31501082
14.
Prediction of prostate cancer aggressiveness using 18F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI.
Sci Rep
; 10(1): 9407, 2020 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32523075
15.
Correlation between 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer.
EJNMMI Res
; 9(1): 50, 2019 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31152256
16.
Neoadjuvant Chemotherapy Does Not Increase the Morbidity of Radical Cystectomy: A 10-year Retrospective Nationwide Study.
Eur Urol Oncol
; 1(6): 525-530, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31158099
17.
Stratification of aggressive prostate cancer from indolent disease-Prospective controlled trial utilizing expression of 11 genes in apparently benign tissue.
Urol Oncol
; 34(6): 255.e15-22, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26857646